News From the 2020 San Antonio Breast Cancer Symposium

<p><span data-sheets-value= "{"1":2,"2":"<p>The San Antonio Breast Cancer Symposium took place virtually from December 8 to 12th. This week, we're featuring three important studies from the meeting, focusing on a new prognostic tool; the treatment of depression and related symptoms in young breast cancer survivors; and a chemoimmunotherapy regimen for triple-negative disease.</p><p>To listen to more podcasts from ASCO, visit <a href=\"https://www.asco.org/about-asco/asco-digital/podcasts\">asco.org/podcasts</a>. <br></p>"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> The San Antonio Breast Cancer Symposium took place virtually from December 8 to 12th. This week, we're featuring three important studies from the meeting, focusing on a new prognostic tool; the treatment of depression and related symptoms in young breast cancer survivors; and a chemoimmunotherapy regimen for triple-negative disease.</span></p>